Clinical Trial Update: The Gastric Bypass Stent System as a Treatment for Hepatic Fibrosis in Obese Patients in European Region [NA]

View source ↗

Summary

A clinical trial evaluating a Gastric Bypass Stent System as a potential treatment for liver fibrosis in obese patients in Europe; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Fibrosis
• Obesity

Drugs mentioned

• Gastric Bypass Stent System

Snippet

Sponsor: MDCECRO LLC | Conditions: Fibrosis, Liver | NA | Status: RECRUITING